BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
6/09/2022 - National Advertising Division Recommends P&G Discontinue Odor Elimination Claims for Febreze Products; P&G to Appeal
New York, NY – June 9, 2022 – The National Advertising Division (NAD) recommended that The Procter & Gamble Company (P&G) discontinue certain “odor elimination” claims that P&G makes across the Febreze line of home fragrance products, which include the Febreze Air, Light, Fabric, Plug, Small Spaces, Candles, Wax Melts, Car, and Unstopable products. P&G will appeal NAD’s decision.
-
6/07/2022 - National Advertising Division Finds Glee Gum’s “Plastic-Free” Claim Supported; Recommends “Made with Chicle,” Unqualified “Natural” Claims be Discontinued
New York, NY – June 7, 2022 – The National Advertising Division (NAD) determined that Mazee, LLC provided a reasonable basis for claims that its Glee Gum is “plastic-free.” However, NAD recommended that the advertiser discontinue claims that the gum base of Glee Gum is “made with chicle,” unqualified natural claims (“natural”, “all-natural,” “100% natural”), as well as its “plant-based” claims, and unqualified “eco-friendly” claims. During the proceeding, the advertiser permanently discontinued and modified several challenged claims. NAD did not review the discontinued claims or pre-modification claims on the merits.
-
6/01/2022 - NAD Finds “Whole Home and Building Purification” Claims for RGF Air Purification Devices Supported; Recommends Certain Other Claims be Discontinued
New York, NY – June 1, 2022 – The National Advertising Division (NAD) determined that RGF Environmental Group, Inc., manufacturer of RGF Air Purification Devices, can make certain general efficacy claims, including that the REME HALO air purifier “provides whole home and building purification.” However, NAD recommended that the advertiser discontinue claims relating to the safety of the emissions generated by the RGF devices, certain quantity-related claims, and others.
-
5/31/2022 - National Advertising Division Recommends i-Health Discontinue Health-Related Claims for Culturelle IBS Complete Support
New York, NY – May 31, 2022 – The National Advertising Division (NAD) of BBB National Programs recommended that i-Health, Inc. (DSM North America) discontinue health-related claims for its Culturelle IBS Complete Support. The claims, which appeared on product packaging, the advertiser’s website, and in third-party online advertising, were challenged by The Procter & Gamble Company (P&G), a competing manufacturer of products aimed at gut health, including those containing probiotics and prebiotics.
-
5/26/2022 - National Advertising Division Finds Certain Google Fiber Claims Supported, with Qualification; Recommends Other Claims be Discontinued
New York, NY – May 26, 2022 – The National Advertising Division (NAD) determined Google Fiber provided a reasonable basis for certain superior speed claims for its fiber service as compared with cable internet providers in its footprint. However, with respect to its “faster in every direction” claim and its “everything you do goes much faster” claim, NAD recommended that the advertiser make certain modifications. The claims at issue were challenged by Charter Communications, Inc.
-
5/26/2022 - National Advertising Division Finds Certain Global Medical Response, Inc. Air Ambulance Transport Advertising Claims Supported, with Qualification
New York, NY – May 26, 2022 – The National Advertising Division (NAD) determined that Global Medical Response, Inc. provided a reasonable basis for certain advertising claims for its Air Ambulance Transport. However, NAD recommended that the advertiser clearly disclose qualifying information related to its AirMedCare Network subscription membership program. The claims at issue were challenged by Air Methods Corporation, a competitor in the emergency air medical transport services industry.
-
5/25/2022 - National Advertising Division Recommends Goli Nutrition Modify or Discontinue Various Claims for Ashwagandha Gummies
New York, NY – May 25, 2022 – The National Advertising Division (NAD) recommended that Goli Nutrition modify its advertising to avoid conveying challenged implied product efficacy claims for its Ashwagandha Gummies dietary supplement and modify or discontinue a qualified claim about the ability of the ingredient KSM-66 Ashwagandha Root Extract to affect physical performance.
-
5/04/2022 - National Advertising Division Finds Certain Apartments.com Website Claims Supported; Advertiser CoStar Group Appeals Other Findings
New York, NY – May 4, 2022 – The National Advertising Division (NAD) determined that CoStar Group, Inc. has a reasonable basis for certain Apartments.com claims, however, NAD recommended that CoStar modify or discontinue certain popularity claims, discontinue several of the challenged conversion and web prevalence claims, and modify or discontinue certain website/service feature claims.
-
4/27/2022 - Brilliant Earth Voluntarily Discontinues “Free Diamond Earrings” and “One Day Only!” Claims Following National Advertising Division Challenge
New York, NY – April 27, 2022 – In a BBB National Programs National Advertising Division (NAD) challenge, Brilliant Earth Group, Inc. voluntarily discontinued claims made in connection with the sale of its diamonds and jewelry. These claims were challenged by competitor Blue Nile.
-
4/26/2022 - National Advertising Division Finds Innovix Pharma Qualified Claims Supported; Recommends Certain OmegaVia Performance Claims be Discontinued
New York, NY – April 26, 2022 – The National Advertising Division (NAD) determined that Innovix Pharma, manufacturer of OmegaVia Fish Oil and OmegaVia EPA dietary supplements, can make qualified claims about EPA and DHA supplementation to support heart health in addition to a healthy diet and exercise, but should discontinue the challenged product performance claims and testimonials relating to heart health and triglyceride management. The claims at issue were challenged by Amarin Pharma, Inc., the manufacturer of the FDA-approved cardiovascular drug Vascepa.